Logo image of YSG

YATSEN HOLDING LTD-ADR (YSG) Stock Fundamental Analysis

NYSE:YSG - US9851942089 - ADR

9.34 USD
-0.32 (-3.31%)
Last: 8/29/2025, 8:04:00 PM
9.34 USD
0 (0%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, YSG scores 4 out of 10 in our fundamental rating. YSG was compared to 36 industry peers in the Personal Care Products industry. While YSG has a great health rating, there are worries on its profitability. YSG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year YSG has reported negative net income.
YSG had negative earnings in each of the past 5 years.
YSG had negative operating cash flow in 4 of the past 5 years.
YSG Yearly Net Income VS EBIT VS OCF VS FCFYSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -15.18%, YSG is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -19.19%, YSG is doing worse than 62.86% of the companies in the same industry.
Industry RankSector Rank
ROA -15.18%
ROE -19.19%
ROIC N/A
ROA(3y)-15.56%
ROA(5y)-23.16%
ROE(3y)-19.51%
ROE(5y)-28.79%
ROIC(3y)N/A
ROIC(5y)N/A
YSG Yearly ROA, ROE, ROICYSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Gross Margin of YSG (77.47%) is better than 91.43% of its industry peers.
YSG's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for YSG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.93%
GM growth 5Y3.93%
YSG Yearly Profit, Operating, Gross MarginsYSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

9

2. Health

2.1 Basic Checks

YSG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YSG has less shares outstanding
YSG has less shares outstanding than it did 5 years ago.
YSG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
YSG Yearly Shares OutstandingYSG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
YSG Yearly Total Debt VS Total AssetsYSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.30 indicates that YSG is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.30, YSG perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
YSG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACCN/A
WACC7.54%
YSG Yearly LT Debt VS Equity VS FCFYSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 4.26 indicates that YSG has no problem at all paying its short term obligations.
YSG has a better Current ratio (4.26) than 88.57% of its industry peers.
A Quick Ratio of 3.53 indicates that YSG has no problem at all paying its short term obligations.
YSG has a better Quick ratio (3.53) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 3.53
YSG Yearly Current Assets VS Current LiabilitesYSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

YSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.61%, which is quite impressive.
YSG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.54%.
YSG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.93% yearly.
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.27%
Revenue 1Y (TTM)-36.54%
Revenue growth 3Y6.93%
Revenue growth 5YN/A
Sales Q2Q%39.42%

3.2 Future

YSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.38% yearly.
YSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.56% yearly.
EPS Next Y68.58%
EPS Next 2Y25.32%
EPS Next 3Y35.64%
EPS Next 5Y26.38%
Revenue Next Year-10.54%
Revenue Next 2Y-4.29%
Revenue Next 3Y1.63%
Revenue Next 5Y8.56%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YSG Yearly Revenue VS EstimatesYSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
YSG Yearly EPS VS EstimatesYSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YSG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for YSG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YSG Price Earnings VS Forward Price EarningsYSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YSG Per share dataYSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

YSG's earnings are expected to grow with 35.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.32%
EPS Next 3Y35.64%

More info and screens

0

5. Dividend

5.1 Amount

YSG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

YATSEN HOLDING LTD-ADR

NYSE:YSG (8/29/2025, 8:04:00 PM)

After market: 9.34 0 (0%)

9.34

-0.32 (-3.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-21 2025-08-21/bmo
Earnings (Next)11-18 2025-11-18
Inst Owners24.18%
Inst Owner Change13.2%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap920.53M
Analysts76.67
Price Target6.94 (-25.7%)
Short Float %10.07%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)308.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.9
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB 2.79
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.91
BVpS4.36
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.18%
ROE -19.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.47%
FCFM N/A
ROA(3y)-15.56%
ROA(5y)-23.16%
ROE(3y)-19.51%
ROE(5y)-28.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.93%
GM growth 5Y3.93%
F-ScoreN/A
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.26
Quick Ratio 3.53
Altman-Z 3.3
F-ScoreN/A
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)32.98%
Cap/Depr(5y)136.75%
Cap/Sales(3y)1.52%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.27%
EPS Next Y68.58%
EPS Next 2Y25.32%
EPS Next 3Y35.64%
EPS Next 5Y26.38%
Revenue 1Y (TTM)-36.54%
Revenue growth 3Y6.93%
Revenue growth 5YN/A
Sales Q2Q%39.42%
Revenue Next Year-10.54%
Revenue Next 2Y-4.29%
Revenue Next 3Y1.63%
Revenue Next 5Y8.56%
EBIT growth 1Y58.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.79%
OCF growth 3YN/A
OCF growth 5YN/A